共 28 条
[21]
Li Q., Wu J., Nie J., Li Z., Hao H., Liu S., Zhao C., Zhang Q., Liu H., Nie L., Qin H., Wang M., Lu Q., Li X., Sun Q., Liu J., Zhang L., Li X., Huang W., Wang Y., The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity, Cell, 182, 5, pp. 1284-1294, (2020)
[22]
Storz J.F., Compensatory mutations and epistasis for protein function, Curr Opin Struct Biol, 50, pp. 18-25, (2018)
[23]
Kong Q., Xiang Z., Wu Y., Gu Y., Guo J., Geng F., Analysis of the susceptibility of lung cancer patients to SARS-CoV-2 infection, Mol Cancer, 19, 1, (2020)
[24]
Zhang H., Quek K., Chen R., Chen J., Chen B., Expression of the SARS-CoV-2 receptor ACE2 reveals the susceptibility of COVID-19 in non-small cell lung cancer, J Cancer, 11, 18, pp. 5289-5292, (2020)
[25]
Uhlen M., Fagerberg L., Hallstrom B.M., Lindskog C., Oksvold P., Mardinoglu A., Sivertsson A., Kampf C., Sjostedt E., Asplund A., Olsson I., Edlund K., Lundberg E., Navani S., Szigyarto C.A., Odeberg J., Djureinovic D., Takanen J.O., Hober S., Alm T., Edqvist P.H., Berling H., Tegel H., Mulder J., Rockberg J., Nilsson P., Schwenk J.M., Hamsten M., von Feilitzen K., Forsberg M., Persson L., Johansson F., Zwahlen M., von Heijne G., Nielsen J., Ponten F., Proteomics. Tissue-based map of the human
[26]
Jyotsana N., King M.R., The Impact of COVID-19 on cancer risk and treatment, Cell Mol Bioeng, 13, 4, pp. 1-7, (2020)
[27]
Allegra A., Pioggia G., Tonacci A., Musolino C., Gangemi S., Cancer and SARS-CoV-2 infection: diagnostic and therapeutic challenges, Cancers (Basel), 12, 6, (2020)
[28]
Rugge M., Zorzi M., Guzzinati S., SARS-CoV-2 infection in the Italian Veneto region: adverse outcomes in patients with cancer, Nat Cancer, 1, pp. 784-788, (2020)